Contact a CleanUP IPF Trial Team

We’re linking those affected by IPF to world-renowned researchers conducting the CleanUp IPF trial at top-ranked medical centers. You have an opportunity to be part of a team working toward cures for this devastating disease. Please contact the CleanUP IPF Trial team listed below to learn more about trial participation.

Study Purpose

The purpose of this study is to compare the effect of standard care, versus standard of care plus antimicrobial therapy (co-trimoxazole or doxycycline), on clinical outcomes in patients diagnosed with idiopathic pulmonary fibrosis (IPF).

Additional Details

This is a randomized, un-blinded, phase III, multi-center clinical trial of an antimicrobial therapy strategy in idiopathic pulmonary fibrosis patients. Our overall hypothesis is that reducing harmful microbial impact with antimicrobial therapy will reduce the risk of non-elective, respiratory hospitalization or death in patients with Idiopathic Pulmonary Fibrosis (IPF).